Phase 2 Generalized Anxiety Disorder trials recruiting now

All Generalized Anxiety Disorder trials, every phase

Other phases for Generalized Anxiety Disorder

Phase 2 Generalized Anxiety Disorder trials

• A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder
  NCT07478744 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder
  NCT07330648 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
  NCT07489651 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · 28 locations
• Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
  NCT06376734 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 6 locations
• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
  NCT06701903 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 51 locations
• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
  NCT06480383 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 56 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.